Business Description
FluoGuide AS
ISIN : DK0061123312
Share Class Description:
FRA:96X: Ordinary SharesTotal Employee Number:
7Compare
Compare
Traded in other countries / regions
FLUO.Sweden96X.Germany IPO Date
2021-03-10Description
FluoGuide AS is a clinical-stage biotechnology company focused on developing drugs that maximize surgical outcomes by making cancer fluorescent. Its technology includes uPAR, which is part of a proteolytic system, and FG001, a product injected into the patient's vein prior to surgery.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.27 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.65 | |||||
Debt-to-EBITDA | -0.65 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -4 | |||||
3-Year EPS without NRI Growth Rate | -5.9 | |||||
3-Year FCF Growth Rate | 6.9 | |||||
3-Year Book Growth Rate | 6.7 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.82 | |||||
9-Day RSI | 37.48 | |||||
14-Day RSI | 36.75 | |||||
3-1 Month Momentum % | -10.13 | |||||
6-1 Month Momentum % | 13.09 | |||||
12-1 Month Momentum % | -4.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 13.7 | |||||
Quick Ratio | 13.7 | |||||
Cash Ratio | 11.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.4 | |||||
Shareholder Yield % | -6.71 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -183.99 | |||||
ROA % | -81.7 | |||||
ROIC % | -231.38 | |||||
3-Year ROIIC % | 378.87 | |||||
ROC (Joel Greenblatt) % | -629.69 | |||||
ROCE % | -124.86 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 8.18 | |||||
Price-to-Tangible-Book | 8.22 | |||||
EV-to-EBIT | -7.28 | |||||
EV-to-EBITDA | -7.37 | |||||
EV-to-FCF | -7.35 | |||||
| Price-to-Net-Current-Asset-Value | 8.48 | |||||
| Price-to-Net-Cash | 11.95 | |||||
Earnings Yield (Greenblatt) % | -13.74 | |||||
FCF Yield % | -12.22 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
FluoGuide AS Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.382 | ||
| Beta | -0.8821 | ||
| 3-Year Sharpe Ratio | -0.64 | ||
| 3-Year Sortino Ratio | -0.85 | ||
| Volatility % | 38.4 | ||
| 14-Day RSI | 36.75 | ||
| 14-Day ATR (€) | 0.1087 | ||
| 20-Day SMA (€) | 2.7795 | ||
| 12-1 Month Momentum % | -4.8 | ||
| 52-Week Range (€) | 2.55 - 4.18 | ||
| Shares Outstanding (Mil) | 16.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
FluoGuide AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
FluoGuide AS Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-27 | In 110 days | ||
| Second quarter earnings results for 2026 | 2026-08-28 | In 19 days | ||
| First quarter earnings results for 2026 | 2026-05-27 | 3.69 (+1.65%) | ||
| General meeting for 2025 | 2026-03-25 15:00 | 3.80 (+0.00%) | ||
| Annual report for 2025 | 2026-02-25 | 3.12 (-2.19%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-25 | 3.12 (-2.19%) | ||
| Third quarter earnings results for 2025 | 2025-11-27 | 3.20 (+2.24%) | ||
| Second quarter earnings results for 2025 | 2025-08-28 | 3.29 (+0.30%) | ||
| First quarter earnings results for 2025 | 2025-05-28 | 3.77 (+2.17%) | ||
| General meeting for 2024 | 2025-03-27 14:00 | 3.31 (-1.93%) |
Show
Entries
FluoGuide AS Frequently Asked Questions
What is FluoGuide AS(FRA:96X)'s stock price today?
The current price of FRA:96X is €2.63. The 52 week high of FRA:96X is €4.18 and 52 week low is €2.55.
When is next earnings date of FluoGuide AS(FRA:96X)?
The next earnings date of FluoGuide AS(FRA:96X) is 2026-08-28 Est..
Does FluoGuide AS(FRA:96X) pay dividends? If so, how much?
FluoGuide AS(FRA:96X) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on FluoGuide AS
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers